Search Results

You searched for : Biopharma

	HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025 HighTide Therapeutics, a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases.... Apr 25
	Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA ... Apr 15
	Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025 Awards highlight Avantor's commitment to the Biopharma industry... Apr 01
	Neovantage Innovation Park Showcases Life Sciences Infrastructure at BioAsia 2025, Hosts Ministerial Visit and Miltenyi Biotec Inauguration The inauguration of Miltenyi Biotec�s facility and our continued expansion demonstrate our commitment to creating an enabling environment for next-generation therapies and healthcare ... Mar 03
	Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for ... Jan 03
	Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau Everest Medicines has also submitted a new drug application for VELSIPITY(R) in Hong Kong, China which has been officially accepted.... Dec 13
	HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024 ... Oct 29
	Pharmacy of the World: How India�s Pharma Might is Saving Billions and Reshaping Global Healthcare The future of global healthcare looks bright, with India playing a pivotal role in advancing medical research, healthcare access, and disease prevention on a global ... Oct 17
	EASD 2024 \| HighTide Therapeutics Presents Oral Reports of Phase 2 Studies Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801).... Sep 11
	Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024 Recognition of Avantor's achievements in downstream processing, single-use systems, and its overall leadership as a biopharma supplier in Korea.... Aug 26
	Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases STP125G is a single-stranded siRNA therapeutics targeting ApoC3 mRNA, based on Sirnaomics proprietary GalAheadTM mxRNA technology.... Jul 24
	HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress Berberine Ursodeoxycholate (HTD1801) Provides a Unique Therapeutic Approach for Patients with Metabolic Liver Disease and Severe Insulin Resistance... Jun 05
	India's (Pharmacy of the World) Status At Risk: Insight�s From Letter to PM Modi by Analysts at Sanford Bernstein Despite its potential, India does not feature prominently in the global healthcare innovation index or patent publications.... Mar 30
	Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024 Recognition reinforces Avantor's commitment to innovation and leadership for biopharma advancement.... Mar 21
	Thermo Fisher Scientific Appoints Srinath Venkatesh as Managing Director for India and South Asia His visionary leadership, proven track record in business expansion and strategic focus on technology and innovation will drive Thermo Fisher toward the next phase of ... Jan 23
	Global Women�s Health Innovation Conference 2023 Save the Date for the most comprehensive women�s health innovation conference in India. Global Women�s Health Innovation Conference 2023 to address health challenges ... Sep 21
	Now that Eyestem is here, Can India now be care free about Dry AMD ? Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide.The investment will allow Eyestem ... Aug 11
	Eyestem raises $6.4M in Series A round The investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials. ... Aug 08
	Prime Minister Modi inaugurated the biotech startup Expo 2022, praising the sector's rapid growth The Biotech Startup Expo 2022 will provide a common platform to connect investors, entrepreneurs, scientists, researchers, industry leaders, manufacturers, bio-incubators, regulators and government officials.... Jun 11
	GLOBALHealthPR turns Global Health Marketing & Communications GLOBALHealthPR, the world’s largest and most dynamic network of independent healthcare agencies has rebranded itself into Global Health Marketing & Communications (GHMC).... Apr 01
	FDA clears MindMed IND for MM-120 in treatment of generalized anxiety disorder FDA clearance leads to first commercial INDfor LSD, enabling initiation of Phase 2b dose-optimization trials of MM-120 in early 2022 - ... Jan 31
	Tonix Pharmaceuticals announces FDA clearance of the IND for potentiated intranasal Oxytocin Indicated for the prevention of Migraine Headache in chronic migraineurs... Nov 30
	Novo Nordisk to Acquire Dicerna Pharma news update 29/11/2021... Nov 29
	AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Latest pharma news updates... Nov 12
	Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain Latest pharma news update... Nov 03
25 Matching result(s) found!

-Advertisements-

Trending Now
	ACT Fibernet Collaborates with Amazon Prime to Offer Prime Lite Benefits to Consumers June 19, 2025
	CARE Hospitals Conducts “The Power of 3” Public Awareness Drive at Punjagutta JunctionJune 19, 2025
	Legalising key population led health services in Thailand is a gamechangerJune 19, 2025
	MGM Healthcare Successfully Performs Rare Endoscopic Skull Base Surgery on a 1-Year-Old with Brain Herniation inside NoseJune 19, 2025
	Asian Paints’ Apcolite All Protek redefines the Gold Standard in Interior Paints with Breakthrough ‘Lotus Effect Technology’June 19, 2025
	The Soft Touch of Tomorrow: Rural India's Lives Are Being Changed by 3D-Printed LimbsJune 19, 2025
	QNET India Celebrates International Yoga Day with Curated Wellness EssentialsJune 18, 2025
	illumine Raises $2.5M Seed Funding to Globally Scale Vertical AI Platform for Childcare ManagementJune 18, 2025
	Mykare Achieves EBITDA-Positive Status in Elective Surgery Vertical with 80% Revenue GrowthJune 18, 2025
	HCG Manavata Cancer Centre Launches Scalp Cooling Therapy To Prevent Chemotherapy-Induced Hair LossJune 18, 2025
	Biohacking in India: From Blue Light Glasses to Metabolic TrackingJune 18, 2025
	AI-Generated Prescriptions: Will They Ever Be Safe Enough?June 18, 2025
	The Role of Panchayats in Public Health: Untapped Potential in Rural GovernanceJune 18, 2025
	When Medicines Stop Working: How Communities in India Are Fighting BackJune 18, 2025
	Archish Fertility & IVF, India’s First 100% Fully Transparent Fertility Lab, Partners with Amaha Health for Holistic Patient Support & Mental WellbeingJune 17, 2025
	Supporting Mental Health in AutismJune 17, 2025
	New guidelines for monitoring IBD patients to prevent bowel cancerJune 17, 2025
	TTK Prestige Launches Tri-Ply Hexamagic Cookware, Blending Non-Stick Innovation with Triply DurabilityJune 17, 2025
	Turning ₹2.35 Crore of Grant into ₹17.9 Crore of Impact: How Villgro-360 ONE’s Capital For Impact is Benefitting Thousands of Marginalised FarmersJune 17, 2025
	Online Chikitsa Mitra Rolls Out Mobile App for Specialized, In-Home HealthcareJune 17, 2025

Search Results

HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025

Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA

Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025

Neovantage Innovation Park Showcases Life Sciences Infrastructure at BioAsia 2025, Hosts Ministerial Visit and Miltenyi Biotec Inauguration

Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy

Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau

HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024

Pharmacy of the World: How India�s Pharma Might is Saving Billions and Reshaping Global Healthcare

EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies

Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024

Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases

HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress

India's (Pharmacy of the World) Status At Risk: Insight�s From Letter to PM Modi by Analysts at Sanford Bernstein

Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024

Thermo Fisher Scientific Appoints Srinath Venkatesh as Managing Director for India and South Asia

Global Women�s Health Innovation Conference 2023

Now that Eyestem is here, Can India now be care free about Dry AMD ?

Eyestem raises $6.4M in Series A round

Prime Minister Modi inaugurated the biotech startup Expo 2022, praising the sector's rapid growth

GLOBALHealthPR turns Global Health Marketing & Communications

FDA clears MindMed IND for MM-120 in treatment of generalized anxiety disorder

Tonix Pharmaceuticals announces FDA clearance of the IND for potentiated intranasal Oxytocin

Novo Nordisk to Acquire Dicerna

AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research

Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain

Trending Now